Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

1.390

+0.010 (0.72%)

At close: Feb 6, 2026, 4:00 PM EST

1.400

+0.010 (0.72%)

After-hours: Feb 6, 2026, 7:59 PM EST

Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	369	415	234	106	395	405
Market Cap Growth	-29.27%	77.46%	120.08%	-73.16%	-2.30%	-46.16%
Enterprise Value	401	484	301	121	363	241
Last Close Price	1.39	1.90	1.24	0.58	2.26	2.80
PS Ratio	1.52	2.59	1.20	0.36	1.87	1.37
PB Ratio	8.86	-8.43	-7.64	20.30	5.34	1.63
P/TBV Ratio	-	-	-	-	-	8.36
P/FCF Ratio	11.46	-	-	-	-	-
P/OCF Ratio	11.39	-	-	-	-	-
EV/Sales Ratio	1.78	3.02	1.55	0.41	1.71	0.82
EV/EBITDA Ratio	12.45	-	-	39.44	-	-
EV/FCF Ratio	12.48	-	-	-	-	-
Debt / Equity Ratio	4.79	-3.84	-4.72	30.07	2.56	0.51
Debt / EBITDA Ratio	5.34	-	-	18.82	-	-
Asset Turnover	0.79	0.69	0.65	0.66	0.36	0.42
Inventory Turnover	1.92	1.64	2.13	0.77	1.67	0.72
Quick Ratio	1.74	1.07	0.82	1.01	0.79	1.59
Current Ratio	1.94	1.41	1.18	1.43	1.04	1.99
Return on Equity (ROE)	-	-	-	-237.83%	-175.37%	-119.82%
Return on Assets (ROA)	4.80%	-12.49%	-9.30%	-4.89%	-24.27%	-15.41%
Return on Capital Employed (ROCE)	9.50%	-33.10%	-31.40%	-15.30%	-84.90%	-38.20%
Earnings Yield	-4.31%	-16.74%	-22.23%	-88.77%	-71.32%	-95.09%
FCF Yield	8.72%	-9.82%	-10.01%	-69.03%	-63.99%	-27.35%
Buyback Yield / Dilution	-20.49%	-12.53%	-2.56%	-10.14%	-19.85%	-16.95%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q